Sabbir Ahmed142-11-3962

OVERVIEW Opsonin Pharma Ltd. (OPL) develops,

manufactures and markets generic medicines for human use.

MISSION

MARKET SHARE OF COMPANIES

Serial Pharma Tk (Crore) Market Share

Growth %

01 Square 1378 19.18 23.54

02 Incepta 650 9.05 32.17

03 Beximco 620 8.62 40.33

04 Opsonin 355 4.94 26.09

05 Eskayef 348 4.84 24.82

Hasan Sikder 142-11-3954

PRODUCTION FACIALITY:

Opsonin Pharma Ltd. operates on 350,000 square feet of manufacturing area.

4000 stakeholders. Opsonin Group employs more than 6000

people.

QUALITY ASSURANCE: Quality Assurance procedures ensure

that the quality of products are maintained.packaging materials and finished product.

Sharmin Afroz 142-11-3963

S.W.O.T• Well diversifies• Strong R & DStrength

• Insufficient working capital.

• Net operating in low cost market.

Weakness

Can add more products to its PFModern Technological advantages

Opportunity Fulfilling the

due commitments

Open market competition

Threat

Farida Hakim 142-11-3980

PESTEL ANALYSIS: Political Factors

Economic Factors

Environmental Factors

Legal Factors

Safia Akther 142-11-3774

PORTER’S 5 FORCE ANALYSIS:

Bargain Power Of Customer. Bargain Power of Supplier. Rivalry Among Existing Firms. Threat of Substitute Products. Threat of new Entrants.

Fahimul Haq 142-11-3968

PORTER’S 5 FORCE ANALYSIS

Buye

r

Supp

lier

Compe

tition

Subst

itute

New En

trants

0%40%80%

Very LowLowModerateHighVery High

Very High High Moderate Low Very LowBuyer 0 0 2 7 3

Supplier 0 2 2 5 3Competitor 1 5 3 2 1Substitute 0 0 3 4 5

New Entrant 6 3 2 1 0

A Small survey on 12 professional shows the following result

CONCLUSION:

The pharmaceutical industry is highly complex. The technologies leading to drug discovery and development are at the limits of human knowledge.